Home
About Us
About Us
Our Team
News & Press
Why Ultra-Rare Diseases
Our Model
Therapy Tracker
Contact
Select Page
Glycerol phenylbutyrate
Back to Therapy Pipeline
Submitting Organization:
STXBP1 Foundation
Treatment Modality:
Small Molecule (repurposed)
Development Stage:
Phase I/II Clinical Trial